{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:10:23Z","timestamp":1790266223992,"version":"4.1.0"},"reference-count":131,"publisher":"Bentham Science Publishers Ltd.","issue":"2","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CPB"],"published-print":{"date-parts":[[2022,2]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Cardiovascular diseases are some of the major causes of morbidity and mortality in developed or developing countries but in developed countries as well. Cardiac fibrosis is one of the most often pathological changes of heart tissues. It occurs as a result of extracellular matrix proteins accumulation at myocardia. Cardiac fibrosis results in impaired cardiac systolic and diastolic functions and is associated with other effects. Therapies with medicines have not been sufficiently successful in treating chronic diseases such as CVD. Therefore, the interest for therapeutic potential of natural compounds and medicinal plants has increased.  Plants such as grapes, berries and peanuts contain a polyphenolic compound called \"resveratrol\" which has been reported to have various therapeutic properties for a variety of diseases. Studies on laboratory models that show that resveratrol has beneficial effects on cardiovascular diseases including myocardial infarction, high blood pressure cardiomyopathy, thrombosis, cardiac fibrosis, and atherosclerosis. In vitro animal models using resveratrol indicated protective effects on the heart by neutralizing reactive oxygen species, preventing inflammation, increasing neoangiogenesis, dilating blood vessels, suppressing apoptosis and delaying atherosclerosis. In this review, we are presenting experimental and clinical results of studies concerning resveratrol effects on cardiac fibrosis as a CVD outcome in humans.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389201022666210212125003","type":"journal-article","created":{"date-parts":[[2021,2,15]],"date-time":"2021-02-15T04:51:27Z","timestamp":1613364687000},"page":"190-200","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["Resveratrol and Cardiac Fibrosis Prevention and Treatment"],"prefix":"10.2174","volume":"23","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1563-3391","authenticated-orcid":true,"given":"Parinaz","family":"Zivarpour","sequence":"first","affiliation":[{"name":"Department of Biological Sciences, Faculty of Basic Sciences, Higher Education Institute of Rab-Rashid, Tabriz, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4932-4212","authenticated-orcid":true,"given":"\u017deljko","family":"Reiner","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, University Hospital Centre Zagreb, School of Medicine, University of Zagreb,\nZagreb, Croatia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0696-9229","authenticated-orcid":true,"given":"Jamal","family":"Hallajzadeh","sequence":"additional","affiliation":[{"name":"Department of Biochemistry and Nutrition, Research Center for Evidence-Based Health Management,\nMaragheh University of Medical Sciences, Maragheh, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6058-981X","authenticated-orcid":true,"given":"Liaosadat","family":"Mirsafaei","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Ramsar Campus, Mazandaran\nUniversity of Medical Sciences, Sari, Iran"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","volume":"41","author":"Mach F.","year":"2020","unstructured":"Mach F.; Baigent C.; Catapano A.L.; Koskinas K.C.; Casula M.; Badimon L.; Chapman M.J.; De Backer G.G.; Delgado V.; Ference B.A.; Graham I.M.; Halliday A.; Landmesser U.; Mihaylova B.; Pedersen T.R.; Riccardi G.; Richter D.J.; Sabatine M.S.; Taskinen M.R.; Tokgozoglu L.; Wiklund O.;  ESC Scientific Document Group. 2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk. Eur Heart J 2020,41(1),111-188","journal-title":"Eur Heart J"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"391","DOI":"10.2741\/s33","volume":"1","author":"Dobaczewski M.","year":"2009","unstructured":"Dobaczewski M.; Frangogiannis N.G.; Chemokines and cardiac fibrosis. Front Biosci (Schol Ed) 2009,1,391-405","journal-title":"Front Biosci (Schol Ed)"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1007\/s00018-013-1349-6","volume":"71","author":"Kong P.","year":"2014","unstructured":"Kong P.; Christia P.; Frangogiannis N.G.; The pathogenesis of cardiac fibrosis. Cell Mol Life Sci 2014,71(4),549-574","journal-title":"Cell Mol Life Sci"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1172\/JCI31044","volume":"117","author":"Berk B.C.","year":"2007","unstructured":"Berk B.C.; Fujiwara K.; Lehoux S.; ECM remodeling in hypertensive heart disease. J Clin Invest 2007,117(3),568-575","journal-title":"J Clin Invest"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"1645","DOI":"10.7150\/ijbs.28103","volume":"14","author":"Ma Z-G.","year":"2018","unstructured":"Ma Z-G.; Yuan Y-P.; Wu H-M.; Zhang X.; Tang Q-Z.; Cardiac fibrosis: new insights into the pathogenesis. Int J Biol Sci 2018,14(12),1645-1657","journal-title":"Int J Biol Sci"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1161\/01.CIR.83.6.1849","volume":"83","author":"Weber K.T.","year":"1991","unstructured":"Weber K.T.; Brilla C.G.; Pathological hypertrophy and cardiac interstitium. Fibrosis and renin-angiotensin-aldosterone system. Circulation 1991,83(6),1849-1865","journal-title":"Circulation"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.mam.2018.07.001","volume":"65","author":"Frangogiannis N.G.","year":"2019","unstructured":"Frangogiannis N.G.; Cardiac fibrosis: Cell biological mechanisms, molecular pathways and therapeutic opportunities. Mol Aspects Med 2019,65,70-99","journal-title":"Mol Aspects Med"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1196\/annals.1380.007","volume":"1080","author":"Banerjee I.","year":"2006","unstructured":"Banerjee I.; Yekkala K.; Borg T.K.; Baudino T.A.; Dynamic interactions between myocytes, fibroblasts, and extracellular matrix. Ann N Y Acad Sci 2006,1080(1),76-84","journal-title":"Ann N Y Acad Sci"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1113\/jphysiol.2007.135038","volume":"583","author":"Chilton L.","year":"2007","unstructured":"Chilton L.; Giles W.R.; Smith G.L.; Evidence of intercellular coupling between co-cultured adult rabbit ventricular myocytes and myofibroblasts. J Physiol 2007,583(Pt 1),225-236","journal-title":"J Physiol"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1161\/CIRCRESAHA.111.243162","volume":"110","author":"Frangogiannis N.G.","year":"2012","unstructured":"Frangogiannis N.G.; Regulation of the inflammatory response in cardiac repair. Circ Res 2012,110(1),159-173","journal-title":"Circ Res"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1161\/01.CIR.100.5.490","volume":"100","author":"Nagueh S.F.","year":"1999","unstructured":"Nagueh S.F.; Mikati I.; Weilbaecher D.; Reardon M.J.; Al-Zaghrini G.J.; Cacela D.; He Z.X.; Letsou G.; Noon G.; Howell J.F.; Espada R.; Verani M.S.; Zoghbi W.A.; Relation of the contractile reserve of hibernating myocardium to myocardial structure in humans. Circulation 1999,100(5),490-496","journal-title":"Circulation"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1016\/j.mcna.2017.04.007","volume":"101","author":"Aggarwal M.","year":"2017","unstructured":"Aggarwal M.; Aggarwal B.; Rao J.; Integrative medicine for cardiovascular disease and prevention. Med Clin North Am 2017,101(5),895-923","journal-title":"Med Clin North Am"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1093\/nutrit\/nux047","volume":"75","author":"Cicero A.F.G.","year":"2017","unstructured":"Cicero A.F.G.; Colletti A.; Bajraktari G.; Descamps O.; Djuric D.M.; Ezhov M.; Fras Z.; Katsiki N.; Langlois M.; Latkovskis G.; Panagiotakos D.B.; Paragh G.; Mikhailidis D.P.; Mitchenko O.; Paulweber B.; Pella D.; Pitsavos C.; Reiner &#x17D;.; Ray K.K.; Rizzo M.; Sahebkar A.; Serban M.C.; Sperling L.S.; Toth P.P.; Vinereanu D.; Vrabl&#xED;k M.; Wong N.D.; Banach M.; Lipid-lowering nutraceuticals in clinical practice: position paper from an International Lipid Expert Panel. Nutr Rev 2017,75(9),731-767","journal-title":"Nutr Rev"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.4161\/cc.7.8.5740","volume":"7","author":"Harikumar K.B.","year":"2008","unstructured":"Harikumar K.B.; Aggarwal B.B.; Resveratrol: a multitargeted agent for age-associated chronic diseases. Cell Cycle 2008,7(8),1020-1035","journal-title":"Cell Cycle"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.mrrev.2007.08.004","volume":"658","author":"Saiko P.","year":"2008","unstructured":"Saiko P.; Szakmary A.; Jaeger W.; Szekeres T.; Resveratrol and its analogs: defense against cancer, coronary disease and neurodegenerative maladies or just a fad? Mutat Res 2008,658(1-2),68-94","journal-title":"Mutat Res"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/nrd2060","volume":"5","author":"Baur J.A.","year":"2006","unstructured":"Baur J.A.; Sinclair D.A.; Therapeutic potential of resveratrol: the in vivo evidence. Nat Rev Drug Discov 2006,5(6),493-506","journal-title":"Nat Rev Drug Discov"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1002\/biof.105","volume":"36","author":"Hsieh T.C.","year":"2010","unstructured":"Hsieh T.C.; Wu J.M.; Resveratrol: Biological and pharmaceutical properties as anticancer molecule. Biofactors 2010,36(5),360-369","journal-title":"Biofactors"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1016\/j.bcp.2004.04.028","volume":"68","author":"Jannin B.","year":"2004","unstructured":"Jannin B.; Menzel M.; Berlot J-P.; Delmas D.; Lan&#xE7;on A.; Latruffe N.; Transport of resveratrol, a cancer chemopreventive agent, to cellular targets: plasmatic protein binding and cell uptake. Biochem Pharmacol 2004,68(6),1113-1118","journal-title":"Biochem Pharmacol"},{"key":"ref=19","first-page":"784","volume":"56","author":"Casper R.F.","year":"1999","unstructured":"Casper R.F.; Quesne M.; Rogers I.M.; Shirota T.; Jolivet A.; Milgrom E.; Savouret J.F.; Resveratrol has antagonist activity on the aryl hydrocarbon receptor: implications for prevention of dioxin toxicity. Mol Pharmacol 1999,56(4),784-790","journal-title":"Mol Pharmacol"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"1742","DOI":"10.1096\/fj.06-5743fje","volume":"20","author":"Lin H-Y.","year":"2006","unstructured":"Lin H-Y.; Lansing L.; Merillon J-M.; Davis F.B.; Tang H-Y.; Shih A.; Vitrac X.; Krisa S.; Keating T.; Cao H.J.; Bergh J.; Quackenbush S.; Davis P.J.; Integrin alphaVbeta3 contains a receptor site for resveratrol. FASEB J 2006,20(10),1742-1744","journal-title":"FASEB J"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"7279","DOI":"10.1021\/jf048794e","volume":"52","author":"Caruso F.","year":"2004","unstructured":"Caruso F.; Tanski J.; Villegas-Estrada A.; Rossi M.; Structural basis for antioxidant activity of trans-resveratrol: ab initio calculations and crystal and molecular structure. J Agric Food Chem 2004,52(24),7279-7285","journal-title":"J Agric Food Chem"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"5253","DOI":"10.1158\/1078-0432.CCR-03-0588","volume":"10","author":"Cao Z.","year":"2004","unstructured":"Cao Z.; Fang J.; Xia C.; Shi X.; Jiang B-H.; trans--3,4,5\u2032-Trihydroxystibene inhibits hypoxia-inducible factor 1&#x3B1; and vascular endothelial growth factor expression in human ovarian cancer cells. Clin Cancer Res 2004,10(15),5253-5263","journal-title":"Clin Cancer Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1016\/0140-6736(92)91277-F","volume":"339","author":"Renaud S.","year":"1992","unstructured":"Renaud S.; de Lorgeril M.; Wine, alcohol, platelets, and the French paradox for coronary heart disease. Lancet 1992,339(8808),1523-1526","journal-title":"Lancet"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1089\/jmf.2004.7.290","volume":"7","author":"Hao H.D.","year":"2004","unstructured":"Hao H.D.; He L.R.; Mechanisms of cardiovascular protection by resveratrol. J Med Food 2004,7(3),290-298","journal-title":"J Med Food"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1016\/S0891-5849(02)00911-5","volume":"33","author":"Asensi M.","year":"2002","unstructured":"Asensi M.; Medina I.; Ortega A.; Carretero J.; Ba&#xF1;o M.C.; Obrador E.; Estrela J.M.; Inhibition of cancer growth by resveratrol is related to its low bioavailability. Free Radic Biol Med 2002,33(3),387-398","journal-title":"Free Radic Biol Med"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1124\/jpet.102.033340","volume":"302","author":"Marier J-F.","year":"2002","unstructured":"Marier J-F.; Vachon P.; Gritsas A.; Zhang J.; Moreau J-P.; Ducharme M.P.; Metabolism and disposition of resveratrol in rats: extent of absorption, glucuronidation, and enterohepatic recirculation evidenced by a linked-rat model. J Pharmacol Exp Ther 2002,302(1),369-373","journal-title":"J Pharmacol Exp Ther"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/S0009-9120(02)00397-1","volume":"36","author":"Goldberg D.M.","year":"2003","unstructured":"Goldberg D.M.; Yan J.; Soleas G.J.; Absorption of three wine-related polyphenols in three different matrices by healthy subjects. Clin Biochem 2003,36(1),79-87","journal-title":"Clin Biochem"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10741-011-9234-6","volume":"16","author":"Das D.K.","year":"2011","unstructured":"Das D.K.; Mukherjee S.; Ray D.; Erratum to: resveratrol and red wine, healthy heart and longevity. Heart Fail Rev 2011,16(4),425-435","journal-title":"Heart Fail Rev"},{"key":"ref=29","volume":"2015","year":"2015","unstructured":"Pagliaro, BPagliaro, B. Santolamazza, C.; Simonelli, F.; Rubattu, S. Phytochemical Compounds and Protection from Cardiovascular Diseases: A State of the Art. BioMed Res Int 2015,2015","journal-title":"BioMed Res Int"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.ajpath.2012.11.009","volume":"182","author":"Kanamori H.","year":"2013","unstructured":"Kanamori H.; Takemura G.; Goto K.; Tsujimoto A.; Ogino A.; Takeyama T.; Kawaguchi T.; Watanabe T.; Morishita K.; Kawasaki M.; Mikami A.; Fujiwara T.; Fujiwara H.; Seishima M.; Minatoguchi S.; Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway. Am J Pathol 2013,182(3),701-713","journal-title":"Am J Pathol"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1161\/01.CIR.0000020689.12472.E0","volume":"106","author":"Kuwahara F.","year":"2002","unstructured":"Kuwahara F.; Kai H.; Tokuda K.; Kai M.; Takeshita A.; Egashira K.; Imaizumi T.; Transforming growth factor-beta function blocking prevents myocardial fibrosis and diastolic dysfunction in pressure-overloaded rats. Circulation 2002,106(1),130-135","journal-title":"Circulation"},{"key":"ref=32","first-page":"H1861","volume":"262","author":"Villarreal F.J.","year":"1992","unstructured":"Villarreal F.J.; Cardiac hypertrophy-induced changes in mRNA levels for TGF-beta 1, fibronectin, and collagen. Dillmann WHJAJoP-H. Physiology C 1992,262(6),H1861-H6","journal-title":"Physiology C"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"1120","DOI":"10.1161\/HYPERTENSIONAHA.106.077537","volume":"49","author":"Koitabashi N.","year":"2007","unstructured":"Koitabashi N.; Arai M.; Kogure S.; Niwano K.; Watanabe A.; Aoki Y.; Maeno T.; Nishida T.; Kubota S.; Takigawa M.; Kurabayashi M.; Increased connective tissue growth factor relative to brain natriuretic peptide as a determinant of myocardial fibrosis. Hypertension 2007,49(5),1120-1127","journal-title":"Hypertension"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1006\/jmcc.2000.1109","volume":"32","author":"Piacentini L.","year":"2000","unstructured":"Piacentini L.; Gray M.; Honbo N.Y.; Chentoufi J.; Bergman M.; Karliner J.S.; Endothelin-1 stimulates cardiac fibroblast proliferation through activation of protein kinase C. J Mol Cell Cardiol 2000,32(4),565-576","journal-title":"J Mol Cell Cardiol"},{"key":"ref=35","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1046\/j.1523-1747.2001.01256.x","volume":"116","author":"Shi-Wen X.","year":"2001","unstructured":"Shi-Wen X.; Denton C.P.; Dashwood M.R.; Holmes A.M.; Bou-Gharios G.; Pearson J.D.; Black C.M.; Abraham D.J.; Fibroblast matrix gene expression and connective tissue remodeling: Role of endothelin-1. J Invest Dermatol 2001,116(3),417-425","journal-title":"J Invest Dermatol"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1291\/hypres.28.787","volume":"28","author":"Shibasaki Y.","year":"2005","unstructured":"Shibasaki Y.; Nishiue T.; Masaki H.; Tamura K.; Matsumoto N.; Mori Y.; Nishikawa M.; Matsubara H.; Iwasaka T.; Impact of the angiotensin ii receptor antagonist, losartan, on myocardial fibrosis in patients with end-stage renal disease: Assessment by ultrasonic integrated backscatter and biochemical markers. Hypertens Res 2005,28(10),787-795","journal-title":"Hypertens Res"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","volume":"113","author":"Shi Y.","year":"2003","unstructured":"Shi Y.; Massagu&#xE9; J.; Mechanisms of TGF-&#x3B2; signaling from cell membrane to the nucleus. Cell 2003,113(6),685-700","journal-title":"Cell"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/37284","volume":"390","author":"Heldin C.H.","year":"1997","unstructured":"Heldin C.H.; Miyazono K.; ten Dijke P.; Tgf-beta signalling from cell membrane to nucleus through smad proteins. Nature 1997,390(6659),465-471","journal-title":"Nature"},{"key":"ref=39","doi-asserted-by":"publisher","DOI":"10.1186\/s12917-018-1387-2.","volume":"14","author":"Lawson J.S.","year":"2018","unstructured":"Lawson J.S.; Syme H.M.; Wheeler-Jones C.P.D.; Elliott J.; Characterisation of feline renal cortical fibroblast cultures and their transcriptional response to transforming growth factor &#x3B2;1. BMC Vet Res 2018,14","journal-title":"BMC Vet Res"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.2337\/diabetes.52.12.2975","volume":"52","author":"Lam S.","year":"2003","unstructured":"Lam S.; van der Geest R.N.; Verhagen N.A.M.; van Nieuwenhoven F.A.; Blom I.E.; Aten J.; Goldschmeding R.; Daha M.R.; van Kooten C.; Connective tissue growth factor and igf-i are produced by human renal fibroblasts and cooperate in the induction of collagen production by high glucose. Diabetes 2003,52(12),2975-2983","journal-title":"Diabetes"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"1774","DOI":"10.1096\/fasebj.13.13.1774","volume":"13","author":"Duncan M.R.","year":"1999","unstructured":"Duncan M.R.; Frazier K.S.; Abramson S.; Williams S.; Klapper H.; Huang X.; Grotendorst G.R.; Connective tissue growth factor mediates transforming growth factor beta-induced collagen synthesis: down-regulation by camp. FASEB J 1999,13(13),1774-1786","journal-title":"FASEB J"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/S0002-9440(10)63562-6","volume":"163","author":"Daniels J.T.","year":"2003","unstructured":"Daniels J.T.; Schultz G.S.; Blalock T.D.; Garrett Q.; Grotendorst G.R.; Dean N.M.; Khaw P.T.; Mediation of transforming growth factor-&#x3B2;1-stimulated matrix contraction by fibroblasts. Am J Pathol 2003,163(5),2043-2052","journal-title":"Am J Pathol"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1096\/fj.03-0699com","volume":"18","author":"Grotendorst G.R.","year":"2004","unstructured":"Grotendorst G.R.; Rahmanie H.; Duncan M.R.; Combinatorial signaling pathways determine fibroblast proliferation and myofibroblast differentiation. FASEB J 2004,18(3),469-479","journal-title":"FASEB J"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/0092-8674(93)90541-W","volume":"75","author":"Sadoshima J.","year":"1993","unstructured":"Sadoshima J.; Xu Y.; Slayter H.S.; Izumo S.; Autocrine release of angiotensin ii mediates stretch-induced hypertrophy of cardiac myocytes in vitro. Cell 1993,75(5),977-984","journal-title":"Cell"},{"key":"ref=45","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1161\/01.CIR.101.10.1130","volume":"101","author":"Kawano H.","year":"2000","unstructured":"Kawano H.; Do Y.S.; Kawano Y.; Starnes V.; Barr M.; Law R.E.; Hsueh W.A.; Angiotensin II has multiple profibrotic effects in human cardiac fibroblasts. Circulation 2000,101(10),1130-1137","journal-title":"Circulation"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1161\/CIRCRESAHA.117.305349","volume":"117","author":"Kamo T.","year":"2015","unstructured":"Kamo T.; Akazawa H.; Komuro I.; Cardiac nonmyocytes in the hub of cardiac hypertrophy. Circ Res 2015,117(1),89-98","journal-title":"Circ Res"},{"key":"ref=47","first-page":"1139","volume":"292","author":"Mitchell M.D.","year":"2007","unstructured":"Mitchell M.D.; Laird R.E.; Brown. Rd il-1&#x3B2; stimulates rat cardiac fibroblast migration via map kinase pathways. Long CSJAJoP-H. Physiol C 2007,292(2),1139-1147","journal-title":"Physiol C"},{"key":"ref=48","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1161\/CIRCRESAHA.109.208199","volume":"105","author":"Honsho S.","year":"2009","unstructured":"Honsho S.; Nishikawa S.; Amano K.; Zen K.; Adachi Y.; Kishita E.; Matsui A.; Katsume A.; Yamaguchi S.; Nishikawa K.; Isoda K.; Riches D.W.H.; Matoba S.; Okigaki M.; Matsubara H.; Pressure-mediated hypertrophy and mechanical stretch induces il-1 release and subsequent igf-1 generation to maintain compensative hypertrophy by affecting akt and jnk pathways. Circ Res 2009,105(11),1149-1158","journal-title":"Circ Res"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0735-1097(96)00268-9","volume":"28","author":"Testa M.","year":"1996","unstructured":"Testa M.; Yeh M.; Lee P.; Fanelli R.; Loperfido F.; Berman J.W.; LeJemtel T.H.; Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996,28(4),964-971","journal-title":"J Am Coll Cardiol"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0735-1097(96)00268-9","volume":"28","author":"Testa M.","year":"1996","unstructured":"Testa M.; Yeh M.; Lee P.; Fanelli R.; Loperfido F.; Berman J.W.; LeJemtel T.H.; Circulating levels of cytokines and their endogenous modulators in patients with mild to severe congestive heart failure due to coronary artery disease or hypertension. J Am Coll Cardiol 1996,28(4),964-971","journal-title":"J Am Coll Cardiol"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/01.RES.81.4.627","volume":"81","author":"Kubota T.","year":"1997","unstructured":"Kubota T.; McTiernan C.F.; Frye C.S.; Slawson S.E.; Lemster B.H.; Koretsky A.P.; Demetris A.J.; Feldman A.M.; Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res 1997,81(4),627-635","journal-title":"Circ Res"},{"key":"ref=52","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1161\/HYPERTENSIONAHA.109.148635","volume":"56","author":"Mel&#xE9;ndez G.C.","year":"2010","unstructured":"Mel&#xE9;ndez G.C.; McLarty J.L.; Levick S.P.; Du Y.; Janicki J.S.; Brower G.L.; Interleukin 6 mediates myocardial fibrosis, concentric hypertrophy, and diastolic dysfunction in rats. Hypertension 2010,56(2),225-231","journal-title":"Hypertension"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"1019","DOI":"10.1161\/CIRCULATIONAHA.114.008788","volume":"131","author":"Frieler R.A.","year":"2015","unstructured":"Frieler R.A.; Mortensen R.M.; Immune cell and other noncardiomyocyte regulation of cardiac hypertrophy and remodeling. Circulation 2015,131(11),1019-1030","journal-title":"Circulation"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/j.matbio.2018.01.013","volume":"68-69","author":"Li L.","year":"2018","unstructured":"Li L.; Zhao Q.; Kong W.; Extracellular matrix remodeling and cardiac fibrosis. Matrix Biol 2018,68-69,490-506","journal-title":"Matrix Biol"},{"key":"ref=55","doi-asserted-by":"publisher","DOI":"10.1155\/2016\/4087632","author":"Krejci J","year":"2016","unstructured":"Krejci J; Mlejnek D; Sochorova D; Nemec P.;  Inflammatory cardiomyopathy: a current view on the pathophysiology, diagnosis, and treatment 2016","journal-title":"Inflammatory cardiomyopathy: a current view on the pathophysiology, diagnosis, and treatment"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"552","DOI":"10.1056\/NEJMoa1002659","volume":"363","author":"Ho C.Y.","year":"2010","unstructured":"Ho C.Y.; L&#xF3;pez B.; Coelho-Filho O.R.; Lakdawala N.K.; Cirino A.L.; Jarolim P.; Kwong R.; Gonz&#xE1;lez A.; Colan S.D.; Seidman J.G.; D&#xED;ez J.; Seidman C.E.; Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy. N Engl J Med 2010,363(6),552-563","journal-title":"N Engl J Med"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1016\/j.jacc.2006.07.049","volume":"48","author":"Assomull R.G.","year":"2006","unstructured":"Assomull R.G.; Prasad S.K.; Lyne J.; Smith G.; Burman E.D.; Khan M.; Sheppard M.N.; Poole-Wilson P.A.; Pennell D.J.; Cardiovascular magnetic resonance, fibrosis, and prognosis in dilated cardiomyopathy. J Am Coll Cardiol 2006,48(10),1977-1985","journal-title":"J Am Coll Cardiol"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/S1760-2734(06)70061-3","volume":"6","author":"Fox P.R.","year":"2004","unstructured":"Fox P.R.; Endomyocardial fibrosis and restrictive cardiomyopathy: pathologic and clinical features. J Vet Cardiol 2004,6(1),25-31","journal-title":"J Vet Cardiol"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1002\/jcp.22322","volume":"225","author":"Krenning G.","year":"2010","unstructured":"Krenning G.; Zeisberg E.M.; Kalluri R.; The origin of fibroblasts and mechanism of cardiac fibrosis. J Cell Physiol 2010,225(3),631-637","journal-title":"J Cell Physiol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"H1871","DOI":"10.1152\/ajpheart.00387.2003","volume":"285","author":"Wang J.","year":"2003","unstructured":"Wang J.; Chen H.; Seth A.; McCulloch C.A.; Mechanical force regulation of myofibroblast differentiation in cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2003,285(5),H1871-H1881","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1016\/j.jbiomech.2009.09.020","volume":"43","author":"Hinz B.","year":"2010","unstructured":"Hinz B.; The myofibroblast: paradigm for a mechanically active cell. J Biomech 2010,43(1),146-155","journal-title":"J Biomech"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.yjmcc.2016.05.002","volume":"97","author":"Stempien-Otero A.","year":"2016","unstructured":"Stempien-Otero A.; Kim D-H.; Davis J.; Molecular networks underlying myofibroblast fate and fibrosis. J Mol Cell Cardiol 2016,97,153-161","journal-title":"J Mol Cell Cardiol"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1186\/s12933-017-0506-x","volume":"16","author":"Lorenzo-Almor&#xF3;s A.","year":"2017","unstructured":"Lorenzo-Almor&#xF3;s A.; Tu&#xF1;&#xF3;n J.; Orejas M.; Cort&#xE9;s M.; Egido J.; Lorenzo &#xD3;.; Diagnostic approaches for diabetic cardiomyopathy. Cardiovasc Diabetol 2017,16(1),28","journal-title":"Cardiovasc Diabetol"},{"key":"ref=64","doi-asserted-by":"publisher","DOI":"10.1002\/path.2277","author":"Wynn TA","unstructured":"Wynn TA;  Cellular and molecular mechanisms of fibrosis The Journal of Pathology: A Journal of the Pathological Society of\tGreat Britain and Ireland, 2008, 214(2), 199-210","journal-title":"Cellular and molecular mechanisms of fibrosis The Journal of Pathology: A Journal of the Pathological Society of\tGreat Britain and Ireland, 2008, 214(2), 199-210"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1161\/CIRCRESAHA.110.217737","volume":"106","author":"Leask A.","year":"2010","unstructured":"Leask A.; Potential therapeutic targets for cardiac fibrosis: TGFbeta, angiotensin, endothelin, CCN2, and PDGF, partners in fibroblast activation. Circ Res 2010,106(11),1675-1680","journal-title":"Circ Res"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s00011-004-1298-5","volume":"53","author":"Frangogiannis N.G.","year":"2004","unstructured":"Frangogiannis N.G.; Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm Res 2004,53(11),585-595","journal-title":"Inflamm Res"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"4532","DOI":"10.1091\/mbc.e04-04-0348","volume":"15","author":"Subramanian S.V.","year":"2004","unstructured":"Subramanian S.V.; Polikandriotis J.A.; Kelm R.J.; David J.J.; Orosz C.G.; Strauch A.R.; Induction of vascular smooth muscle &#x3B1;-actin gene transcription in transforming growth factor &#x3B2;1-activated myofibroblasts mediated by dynamic interplay between the Pur repressor proteins and Sp1\/Smad coactivators. Mol Biol Cell 2004,15(10),4532-4543","journal-title":"Mol Biol Cell"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1161\/CIRCRESAHA.110.223172","volume":"107","author":"Small E.M.","year":"2010","unstructured":"Small E.M.; Thatcher J.E.; Sutherland L.B.; Kinoshita H.; Gerard R.D.; Richardson J.A.; Novelty and significance. Circ Res 2010,107(2),294-304","journal-title":"Circ Res"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.1172\/JCI94753","volume":"127","author":"Khalil H.","year":"2017","unstructured":"Khalil H.; Kanisicak O.; Prasad V.; Correll R.N.; Fu X.; Schips T.; Vagnozzi R.J.; Liu R.; Huynh T.; Lee S.J.; Karch J.; Molkentin J.D.; Fibroblast-specific TGF-&#x3B2;-Smad2\/3 signaling underlies cardiac fibrosis. J Clin Invest 2017,127(10),3770-3783","journal-title":"J Clin Invest"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"3037","DOI":"10.1084\/jem.20070885","volume":"204","author":"Nahrendorf M.","year":"2007","unstructured":"Nahrendorf M.; Swirski F.K.; Aikawa E.; Stangenberg L.; Wurdinger T.; Figueiredo J-L.; Libby P.; Weissleder R.; Pittet M.J.; The healing myocardium sequentially mobilizes two monocyte subsets with divergent and complementary functions. J Exp Med 2007,204(12),3037-3047","journal-title":"J Exp Med"},{"key":"ref=71","author":"Kong P","unstructured":"Kong P; Christia P; Frangogiannis NGJC;  The pathogenesis of cardiac fibrosis Sciences ml, 2014, 71(4), 549-74","journal-title":"The pathogenesis of cardiac fibrosis Sciences ml, 2014, 71(4), 549-74"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.immuni.2005.10.001","volume":"23","author":"Mantovani A.","year":"2005","unstructured":"Mantovani A.; Sica A.; Locati M.; Macrophage polarization comes of age. Immunity 2005,23(4),344-346","journal-title":"Immunity"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1161\/ATVBAHA.112.248732","volume":"32","author":"Yang M.","year":"2012","unstructured":"Yang M.; Zheng J.; Miao Y.; Wang Y.; Cui W.; Guo J.; Qiu S.; Han Y.; Jia L.; Li H.; Cheng J.; Du J.; Serum-glucocorticoid regulated kinase 1 regulates alternatively activated macrophage polarization contributing to angiotensin ii-induced inflammation and cardiac fibrosis. Arterioscler Thromb Vasc Biol 2012,32(7),1675-1686","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.HYP.0000111831.50834.93","volume":"43","author":"Tokuda K.","year":"2004","unstructured":"Tokuda K.; Kai H.; Kuwahara F.; Yasukawa H.; Tahara N.; Kudo H.; Takemiya K.; Koga M.; Yamamoto T.; Imaizumi T.; Pressure-independent effects of angiotensin ii on hypertensive myocardial fibrosis. Hypertension 2004,43(2),499-503","journal-title":"Hypertension"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","volume":"161","author":"Sun Y.","year":"2002","unstructured":"Sun Y.; Zhang J.; Lu L.; Chen S.S.; Quinn M.T.; Weber K.T.; Aldosterone-induced inflammation in the rat heart&#x202F;: role of oxidative stress. Am J Pathol 2002,161(5),1773-1781","journal-title":"Am J Pathol"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"5288","DOI":"10.4049\/jimmunol.178.8.5288","volume":"178","author":"Fallowfield J.A.","year":"2007","unstructured":"Fallowfield J.A.; Mizuno M.; Kendall T.J.; Constandinou C.M.; Benyon R.C.; Duffield J.S.; Iredale J.P.; Scar-associated macrophages are a major source of hepatic matrix metalloproteinase-13 and facilitate the resolution of murine hepatic fibrosis. J Immunol 2007,178(8),5288-5295","journal-title":"J Immunol"},{"key":"ref=77","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1119964109","author":"Ramachandran P","unstructured":"Ramachandran P; Pellicoro A; Vernon MA; Boulter L; Aucott RL;  ; Ali, A Differential Ly-6C expression identifies the recruited\nmacrophage phenotype, which orchestrates the regression of murine\nliver fibrosis, 2012, 109(46), E3186-E95","journal-title":"; Ali, A Differential Ly-6C expression identifies the recruited\nmacrophage phenotype, which orchestrates the regression of murine\nliver fibrosis, 2012, 109(46), E3186-E95"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1172\/JCI44824","volume":"121","author":"Koitabashi N.","year":"2011","unstructured":"Koitabashi N.; Danner T.; Zaiman A.L.; Pinto Y.M.; Rowell J.; Mankowski J.; Zhang D.; Nakamura T.; Takimoto E.; Kass D.A.; Pivotal role of cardiomyocyte TGF-&#x3B2; signaling in the murine pathological response to sustained pressure overload. J Clin Invest 2011,121(6),2301-2312","journal-title":"J Clin Invest"},{"key":"ref=79","first-page":"215","author":"Barallobre-Barreiro J.","year":"2013","unstructured":"Barallobre-Barreiro J.; Didangelos A.; Yin X.; Dom&#xE9;nech N.; Mayr M.;  A sequential extraction methodology for cardiac extracellular matrix prior to proteomics analysis 2013,215-223","journal-title":"A sequential extraction methodology for cardiac extracellular matrix prior to proteomics analysis"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.yjmcc.2015.12.019","volume":"91","author":"Fang M.","year":"2016","unstructured":"Fang M.; Xiang F-L.; Braitsch C.M.; Yutzey K.E.; Epicardium-derived fibroblasts in heart development and disease. J Mol Cell Cardiol 2016,91,23-27","journal-title":"J Mol Cell Cardiol"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/1755-1536-5-15","volume":"5","author":"Fan D.","year":"2012","unstructured":"Fan D.; Takawale A.; Lee J.; Kassiri Z.; Cardiac fibroblasts, fibrosis and extracellular matrix remodeling in heart disease. Fibrogenesis Tissue Repair 2012,5(1),15","journal-title":"Fibrogenesis Tissue Repair"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/j.tcm.2018.08.007","volume":"29","author":"Nebigil C.G.","year":"2019","unstructured":"Nebigil C.G.; D&#xE9;saubry L.; The role of GPCR signaling in cardiac Epithelial to Mesenchymal Transformation (EMT). Trends Cardiovasc Med 2019,29(4),200-204","journal-title":"Trends Cardiovasc Med"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"672","DOI":"10.1016\/j.tips.2018.04.002","volume":"39","author":"Gurevich V.V.","year":"2018","unstructured":"Gurevich V.V.; Gurevich E.V.; GPCRs and signal transducers: interaction stoichiometry. Trends Pharmacol Sci 2018,39(7),672-684","journal-title":"Trends Pharmacol Sci"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"H424","DOI":"10.1152\/ajpheart.00454.2014","volume":"308","author":"Chen T.","year":"2015","unstructured":"Chen T.; Li J.; Liu J.; Li N.; Wang S.; Liu H.; Zeng M.; Zhang Y.; Bu P.; Activation of SIRT3 by resveratrol ameliorates cardiac fibrosis and improves cardiac function via the TGF-&#x3B2;\/Smad3 pathway. Am J Physiol Heart Circ Physiol 2015,308(5),H424-H434","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"258","DOI":"10.1016\/j.ygeno.2004.11.003","volume":"85","author":"Bellizzi D.","year":"2005","unstructured":"Bellizzi D.; Rose G.; Cavalcante P.; Covello G.; Dato S.; De Rango F.; Greco V.; Maggiolini M.; Feraco E.; Mari V.; Franceschi C.; Passarino G.; De Benedictis G.; A novel VNTR enhancer within the SIRT3 gene, a human homologue of SIR2, is associated with survival at oldest ages. Genomics 2005,85(2),258-263","journal-title":"Genomics"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"6384","DOI":"10.1128\/MCB.00426-08","volume":"28","author":"Sundaresan N.R.","year":"2008","unstructured":"Sundaresan N.R.; Samant S.A.; Pillai V.B.; Rajamohan S.B.; Gupta M.P.; SIRT3 is a stress-responsive deacetylase in cardiomyocytes that protects cells from stress-mediated cell death by deacetylation of Ku70. Mol Cell Biol 2008,28(20),6384-6401","journal-title":"Mol Cell Biol"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"6042","DOI":"10.1039\/C9FO01075K","volume":"10","author":"Hoseini A.","year":"2019","unstructured":"Hoseini A.; Namazi G.; Farrokhian A.; Reiner &#x17D;.; Aghadavod E.; Bahmani F.; Asemi Z.; The effects of resveratrol on metabolic status in patients with type 2 diabetes mellitus and coronary heart disease. Food Funct 2019,10(9),6042-6051","journal-title":"Food Funct"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.cardiores.2006.10.002.","volume":"74","author":"Bujak M.","year":"2007","unstructured":"Bujak M.; Frangogiannis N.G.; The role of tgf-beta signaling in myocardial infarction and cardiac remodeling. Cardiovasc Res 2007,74(2),184-195","journal-title":"Cardiovasc Res"},{"key":"ref=89","author":"Dobaczewski M","unstructured":"Dobaczewski M;  Chen, W Transforming growth factor (TGF)-&#x3B2;\nsignaling in cardiac remodeling cardiology c, 2011, 51(4), 600-6","journal-title":"Chen, W Transforming growth factor (TGF)-&#x3B2;\nsignaling in cardiac remodeling cardiology c, 2011, 51(4), 600-6"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1038\/nature01960","volume":"425","author":"Howitz K.T.","year":"2003","unstructured":"Howitz K.T.; Bitterman K.J.; Cohen H.Y.; Lamming D.W.; Lavu S.; Wood J.G.; Zipkin R.E.; Chung P.; Kisielewski A.; Zhang L.L.; Scherer B.; Sinclair D.A.; Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003,425(6954),191-196","journal-title":"Nature"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"1723","DOI":"10.1016\/j.bbadis.2013.05.018","volume":"1832","author":"Dolinsky V.W.","year":"2013","unstructured":"Dolinsky V.W.; Chakrabarti S.; Pereira T.J.; Oka T.; Levasseur J.; Beker D.; Zordoky B.N.; Morton J.S.; Nagendran J.; Lopaschuk G.D.; Davidge S.T.; Dyck J.R.; Resveratrol prevents hypertension and cardiac hypertrophy in hypertensive rats and mice. Biochim Biophys Acta 2013,1832(10),1723-1733","journal-title":"Biochim Biophys Acta"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/nature05354","volume":"444","author":"Baur J.A.","year":"2006","unstructured":"Baur J.A.; Pearson K.J.; Price N.L.; Jamieson H.A.; Lerin C.; Kalra A.; Prabhu V.V.; Allard J.S.; Lopez-Lluch G.; Lewis K.; Pistell P.J.; Poosala S.; Becker K.G.; Boss O.; Gwinn D.; Wang M.; Ramaswamy S.; Fishbein K.W.; Spencer R.G.; Lakatta E.G.; Le Couteur D.; Shaw R.J.; Navas P.; Puigserver P.; Ingram D.K.; de Cabo R.; Sinclair D.A.; Resveratrol improves health and survival of mice on a high-calorie diet. Nature 2006,444(7117),337-342","journal-title":"Nature"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1016\/j.cmet.2008.06.011","volume":"8","author":"Pearson K.J.","year":"2008","unstructured":"Pearson K.J.; Baur J.A.; Lewis K.N.; Peshkin L.; Price N.L.; Labinskyy N.; Swindell W.R.; Kamara D.; Minor R.K.; Perez E.; Jamieson H.A.; Zhang Y.; Dunn S.R.; Sharma K.; Pleshko N.; Woollett L.A.; Csiszar A.; Ikeno Y.; Le Couteur D.; Elliott P.J.; Becker K.G.; Navas P.; Ingram D.K.; Wolf N.S.; Ungvari Z.; Sinclair D.A.; de Cabo R.; Resveratrol delays age-related deterioration and mimics transcriptional aspects of dietary restriction without extending life span. Cell Metab 2008,8(2),157-168","journal-title":"Cell Metab"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"H833","DOI":"10.1152\/ajpheart.00418.2009","volume":"298","author":"Sulaiman M.","year":"2010","unstructured":"Sulaiman M.; Matta M.J.; Sunderesan N.R.; Gupta M.P.; Periasamy M.; Gupta M.; Resveratrol, an activator of SIRT1, upregulates sarcoplasmic calcium ATPase and improves cardiac function in diabetic cardiomyopathy. Am J Physiol Heart Circ Physiol 2010,298(3),H833-H843","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/nature02789","volume":"430","author":"Wood J.G.","year":"2004","unstructured":"Wood J.G.; Rogina B.; Lavu S.; Howitz K.; Helfand S.L.; Tatar M.; Sinclair D.; Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004,430(7000),686-689","journal-title":"Nature"},{"key":"ref=96","doi-asserted-by":"publisher","DOI":"10.1155\/2017\/4602715","author":"Ma S","unstructured":"Ma S; Feng J; Zhang R; Chen J; Han D; Li X;  SIRT1 activation by resveratrol alleviates cardiac dysfunction via mitochondrial regulation in diabetic cardiomyopathy miceOxidative medicine and cellular longevit, 2017","journal-title":"SIRT1 activation by resveratrol alleviates cardiac dysfunction via mitochondrial regulation in diabetic cardiomyopathy miceOxidative medicine and cellular longevit, 2017"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.1161\/CIRCULATIONAHA.107.704197","volume":"116","author":"Bujak M.","year":"2007","unstructured":"Bujak M.; Ren G.; Kweon H.J.; Dobaczewski M.; Reddy A.; Taffet G.; Wang X-F.; Frangogiannis N.G.; Essential role of smad3 in infarct healing and in the pathogenesis of cardiac remodeling. Circulation 2007,116(19),2127-2138","journal-title":"Circulation"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1038\/35043051","volume":"1","author":"Massagu&#xE9; J.","year":"2000","unstructured":"Massagu&#xE9; J.; How cells read tgf-beta signals. Nat Rev Mol Cell Biol 2000,1(3),169-178","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"41361","DOI":"10.1074\/jbc.M204597200.","volume":"277","author":"Funaba M.","year":"2002","unstructured":"Funaba M.; Zimmerman C.M.; Mathews L.S.; Modulation of Smad2-mediated signaling by extracellular signal-regulated kinase. J Biol Chem 2002,277(44),41361-41368","journal-title":"J Biol Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"37413","DOI":"10.1074\/jbc.274.52.37413.","volume":"274","author":"Engel M.E.","year":"1999","unstructured":"Engel M.E.; McDonnell M.A.; Law B.K.; Moses H.L.; Interdependent smad and jnk signaling in transforming growth factor-&#x3B2;-mediated transcription. J Biol Chem 1999,274(52),37413-37420","journal-title":"J Biol Chem"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"H2078","DOI":"10.1152\/ajpheart.01363.2007","volume":"294","author":"Venkatachalam K.","year":"2008","unstructured":"Venkatachalam K.; Mummidi S.; Cortez D.M.; Prabhu S.D.; Valente A.J.; Chandrasekar B.; Resveratrol inhibits high glucose-induced PI3K\/Akt\/ERK-dependent interleukin-17 expression in primary mouse cardiac fibroblasts. Am J Physiol Heart Circ Physiol 2008,294(5),H2078-H2087","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1146\/annurev.pharmtox.45.120403.095802","volume":"45","author":"Brown R.D.","year":"2005","unstructured":"Brown R.D.; Ambler S.K.; Mitchell M.D.; Long C.S.; The cardiac fibroblast: therapeutic target in myocardial remodeling and failure. Annu Rev Pharmacol Toxicol 2005,45,657-687","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"ref=103","author":"Eghbali M.","unstructured":"Eghbali M.;  Cardiac fibroblasts: function, regulation of gene expression, and phenotypic modulationCardiac adaptation in heart failure, 1992, , 183-189","journal-title":"Cardiac fibroblasts: function, regulation of gene expression, and phenotypic modulationCardiac adaptation in heart failure, 1992, , 183-189"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0008-6363(01)00434-5","volume":"53","author":"Frangogiannis N.G.","year":"2002","unstructured":"Frangogiannis N.G.; Smith C.W.; Entman M.L.; The inflammatory response in myocardial infarction. Cardiovasc Res 2002,53(1),31-47","journal-title":"Cardiovasc Res"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/j.yjmcc.2005.01.014","volume":"38","author":"Prabhu S.D.","year":"2005","unstructured":"Prabhu S.D.; Post-infarction ventricular remodeling: an array of molecular events. J Mol Cell Cardiol 2005,38(4),547-550","journal-title":"J Mol Cell Cardiol"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/S1071-9164(96)80047-9","volume":"2","author":"Seta Y.","year":"1996","unstructured":"Seta Y.; Shan K.; Bozkurt B.; Oral H.; Mann D.L.; Basic mechanisms in heart failure: the cytokine hypothesis. J Card Fail 1996,2(3),243-249","journal-title":"J Card Fail"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"623","DOI":"10.3109\/07853890109002108","volume":"33","author":"Wilson E.M.","year":"2001","unstructured":"Wilson E.M.; Spinale F.G.; Myocardial remodelling and matrix metalloproteinases in heart failure: turmoil within the interstitium. Ann Med 2001,33(9),623-634","journal-title":"Ann Med"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"H227","DOI":"10.1152\/ajpheart.00340.2004","volume":"288","author":"Asbun J.","year":"2005","unstructured":"Asbun J.; Manso A.M.; Villarreal F.J.; Profibrotic influence of high glucose concentration on cardiac fibroblast functions: effects of losartan and vitamin E. Am J Physiol Heart Circ Physiol 2005,288(1),H227-H234","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"693","DOI":"10.1016\/j.jacc.2005.09.050","volume":"47","author":"Asbun J.","year":"2006","unstructured":"Asbun J.; Villarreal F.J.; The pathogenesis of myocardial fibrosis in the setting of diabetic cardiomyopathy. J Am Coll Cardiol 2006,47(4),693-700","journal-title":"J Am Coll Cardiol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"1589","DOI":"10.2337\/diacare.26.5.1589","volume":"26","author":"Ceriello A.","year":"2003","unstructured":"Ceriello A.; New insights on oxidative stress and diabetic complications may lead to a &#x201C;causal&#x201D; antioxidant therapy. Diabetes Care 2003,26(5),1589-1596","journal-title":"Diabetes Care"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.2337\/diabetes.53.2007.S110","volume":"53","author":"Green K.","year":"2004","unstructured":"Green K.; Brand M.D.; Murphy M.P.; Prevention of mitochondrial oxidative damage as a therapeutic strategy in diabetes. Diabetes 2004,53(Suppl. 1),S110-S118","journal-title":"Diabetes"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/1475-2840-4-5","volume":"4","author":"Johansen J.S.","year":"2005","unstructured":"Johansen J.S.; Harris A.K.; Rychly D.J.; Ergul A.; Oxidative stress and the use of antioxidants in diabetes: linking basic science to clinical practice. Cardiovasc Diabetol 2005,4(1),5","journal-title":"Cardiovasc Diabetol"},{"key":"ref=113","doi-asserted-by":"publisher","DOI":"10.1155\/2018\/2150218","author":"Wang G.","year":"2018","unstructured":"Wang G.; Song X.; Zhao L.; Li Z.; Liu B.; Resveratrol prevents diabetic cardiomyopathy by increasing Nrf2 expression and transcriptional activity. BioMed Research international 2018","journal-title":"BioMed Research international"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1038\/ni1254","volume":"6","author":"Harrington L.E.","year":"2005","unstructured":"Harrington L.E.; Hatton R.D.; Mangan P.R.; Turner H.; Murphy T.L.; Murphy K.M.; Weaver C.T.; Interleukin 17-producing CD4+ effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat Immunol 2005,6(11),1123-1132","journal-title":"Nat Immunol"},{"key":"ref=115","author":"Huang S-h.","year":"2004","unstructured":"Huang S-h.; Brett E.; Frydas S.; Kempuraj D.; Barbacane R.C.; Grilli A.;  Huang, S-h; Brett, E; Frydas, S; Kempuraj, D; Barbacane, RC;\nGrilli, A, Eds; Interleukin-17 and the interleukin-17 family member\nnetwork 2004","journal-title":"Huang, S-h; Brett, E; Frydas, S; Kempuraj, D; Barbacane, RC;\nGrilli, A, Eds; Interleukin-17 and the interleukin-17 family member\nnetwork"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1038\/ni1261","volume":"6","author":"Park H.","year":"2005","unstructured":"Park H.; Li Z.; Yang X.O.; Chang S.H.; Nurieva R.; Wang Y-H.; Wang Y.; Hood L.; Zhu Z.; Tian Q.; Dong C.; A distinct lineage of CD4 T cells regulates tissue inflammation by producing interleukin 17. Nat Immunol 2005,6(11),1133-1141","journal-title":"Nat Immunol"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1902\/jop.2007.060392","volume":"78","author":"Kramer J.M.","year":"2007","unstructured":"Kramer J.M.; Gaffen S.L.; Interleukin-17: a new paradigm in inflammation, autoimmunity, and therapy. J Periodontol 2007,78(6),1083-1093","journal-title":"J Periodontol"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"H3356","DOI":"10.1152\/ajpheart.00928.2007","volume":"293","author":"Cortez D.M.","year":"2007","unstructured":"Cortez D.M.; Feldman M.D.; Mummidi S.; Valente A.J.; Steffensen B.; Vincenti M.; Barnes J.L.; Chandrasekar B.; IL-17 stimulates MMP-1 expression in primary human cardiac fibroblasts via p38 MAPK- and ERK1\/2-dependent C\/EBP-&#x3B2;, NF-kappaB, and AP-1 activation. Am J Physiol Heart Circ Physiol 2007,293(6),H3356-H3365","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.gde.2009.11.002","volume":"20","author":"Wong K-K.","year":"2010","unstructured":"Wong K-K.; Engelman J.A.; Cantley L.C.; Targeting the PI3K signaling pathway in cancer. Curr Opin Genet Dev 2010,20(1),87-90","journal-title":"Curr Opin Genet Dev"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.imlet.2006.11.001","volume":"108","author":"Cho M-L.","year":"2007","unstructured":"Cho M-L.; Ju J.H.; Kim K-W.; Moon Y-M.; Lee S-Y.; Min S-Y.; Cho Y.G.; Kim H.S.; Park K.S.; Yoon C.H.; Lee S.H.; Park S.H.; Kim H.Y.; Cyclosporine A inhibits IL-15-induced IL-17 production in CD4+ T cells via down-regulation of PI3K\/Akt and NF-kappaB. Immunol Lett 2007,108(1),88-96","journal-title":"Immunol Lett"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12872-015-0169-z","volume":"16","author":"Wu H.","year":"2016","unstructured":"Wu H.; Li G-N.; Xie J.; Li R.; Chen Q-H.; Chen J-Z.; Wei Z.H.; Kang L.N.; Xu B.; Resveratrol ameliorates myocardial fibrosis by inhibiting ROS\/ERK\/TGF-&#x3B2;\/periostin pathway in STZ-induced diabetic mice. BMC Cardiovasc Disord 2016,16(1),5","journal-title":"BMC Cardiovasc Disord"},{"key":"ref=122","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.201900418","volume":"63","author":"Zou L.X.","year":"2019","unstructured":"Zou L.X.; Chen C.; Yan X.; Lin Q.Y.; Fang J.; Li P.B.; Han X.; Wang Q.S.; Guo S.B.; Li H.H.; Zhang Y.L.; Resveratrol attenuates pressure overload-induced cardiac fibrosis and diastolic dysfunction via pten\/akt\/smad2\/3 and nf-&#x3BA;b signaling pathways. Mol Nutr Food Res 2019,63(24)","journal-title":"Mol Nutr Food Res"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/j.redox.2018.10.021","volume":"20","author":"Chen C.","year":"2019","unstructured":"Chen C.; Zou L-X.; Lin Q-Y.; Yan X.; Bi H-L.; Xie X.; Wang S.; Wang Q.S.; Zhang Y.L.; Li H.H.; Resveratrol as a new inhibitor of immunoproteasome prevents PTEN degradation and attenuates cardiac hypertrophy after pressure overload. Redox Biol 2019,20,390-401","journal-title":"Redox Biol"},{"key":"ref=124","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/568634","author":"Liu F-C.","year":"2015","unstructured":"Liu F-C.; Tsai H-I.; Yu H-P.; Organ-protective effects of red wine extract, resveratrol, in oxidative stress-mediated reperfusion injury. Oxidative medicine and cellular longev 2015","journal-title":"Oxidative medicine and cellular longev"},{"key":"ref=125","doi-asserted-by":"publisher","first-page":"1643","DOI":"10.1161\/CIRCULATIONAHA.108.787440","volume":"119","author":"Dolinsky V.W.","year":"2009","unstructured":"Dolinsky V.W.; Chan A.Y.; Robillard Frayne I.; Light P.E.; Des Rosiers C.; Dyck J.R.; Clinical perspective. Circulation 2009,119(12),1643-1652","journal-title":"Circulation"},{"key":"ref=126","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1177\/1479164113520332","volume":"11","author":"Guo R.","year":"2014","unstructured":"Guo R.; Liu B.; Wang K.; Zhou S.; Li W.; Xu Y.; Resveratrol ameliorates diabetic vascular inflammation and macrophage infiltration in db\/db mice by inhibiting the NF-&#x3BA;B pathway. Diab Vasc Dis Res 2014,11(2),92-102","journal-title":"Diab Vasc Dis Res"},{"key":"ref=127","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s13105-018-0648-7","volume":"75","author":"Diao J.","year":"2019","unstructured":"Diao J.; Wei J.; Yan R.; Fan G.; Lin L.; Chen M.; Effects of resveratrol on regulation on UCP2 and cardiac function in diabetic rats. J Physiol Biochem 2019,75(1),39-51","journal-title":"J Physiol Biochem"},{"key":"ref=128","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1161\/CIRCHEARTFAILURE.114.001677","volume":"8","author":"Sung M.M.","year":"2015","unstructured":"Sung M.M.; Das S.K.; Levasseur J.; Byrne N.J.; Fung D.; Kim T.T.; Masson G.; Boisvenue J.; Soltys C.L.; Oudit G.Y.; Dyck J.R.; Resveratrol treatment of mice with pressure-overload-induced heart failure improves diastolic function and cardiac energy metabolism. Circ Heart Fail 2015,8(1),128-137","journal-title":"Circ Heart Fail"},{"key":"ref=129","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1161\/HYPERTENSIONAHA.117.10390","volume":"71","author":"Li J.","year":"2018","unstructured":"Li J.; Wang S.; Bai J.; Yang X-L.; Zhang Y-L.; Che Y-L.; Li H.H.; Yang Y.Z.; Novel role for the Immunoproteasome subunit PSMB10 in angiotensin II\u2013induced atrial fibrillation in mice. Hypertension 2018,71(5),866-876","journal-title":"Hypertension"},{"key":"ref=130","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1164\/rccm.200507-1058OC","volume":"173","author":"White E.S.","year":"2006","unstructured":"White E.S.; Atrasz R.G.; Hu B.; Phan S.H.; Stambolic V.; Mak T.W.; Hogaboam C.M.; Flaherty K.R.; Martinez F.J.; Kontos C.D.; Toews G.B.; Negative regulation of myofibroblast differentiation by PTEN (Phosphatase and Tensin Homolog Deleted on chromosome 10). Am J Respir Crit Care Med 2006,173(1),112-121","journal-title":"Am J Respir Crit Care Med"},{"key":"ref=131","doi-asserted-by":"publisher","DOI":"10.1016\/j.cyto.2011.03.024","author":"Voloshenyuk T.G.","unstructured":"Voloshenyuk T.G.; Landesman E.S.; Khoutorova E.; Hart A.D.; Gardner J.D.;  Induction of cardiac fibroblast lysyl oxidase by TGF-\n&#x3B2;1 requires PI3K\/Akt, Smad3, and MAPK signaling Cytokine,\n2011, 55(1), 90-97","journal-title":"Induction of cardiac fibroblast lysyl oxidase by TGF-\n&#x3B2;1 requires PI3K\/Akt, Smad3, and MAPK signaling Cytokine,\n2011, 55(1), 90-97"}],"container-title":["Current Pharmaceutical Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/191366","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/191366\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download\/191366","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T10:39:00Z","timestamp":1648377540000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/191366\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,2]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389201022666210212125003","relation":{},"ISSN":["1389-2010"],"issn-type":[{"value":"1389-2010","type":"print"}],"subject":[],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2020-08-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-11-17","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2020-12-23","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-12-30","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}